Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.
about
Predictive value of phosphorylated mammalian target of rapamycin for disease-free survival in breast cancer patients receiving neoadjuvant chemotherapy.Survivin, Ki-67 and tumor grade as predictors of response to docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer.Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia.Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor.Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
P2860
Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.
@en
type
label
Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.
@en
prefLabel
Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.
@en
P2860
P50
P1433
P1476
Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy
@en
P2860
P304
P356
10.3109/07357907.2012.725441
P577
2012-09-28T00:00:00Z